Analyst Ratings for Momenta Pharmaceuticals (MNTA) [Sells]

Overall Rating: NEUTRAL Rating Trend:

Avg. $ Target: $20.38 (+52.2%)

Date	Firm	Type	Rating (Past)	PT (Past)	Start $	End $	% Chg.	Details
3/19/2013	BofA/Merrill Lynch	Downgrade	Underperform (Neutral)	N/A (N/A)	13.86	13.39	-3.39%	Details

Like MNTA Ratings? Also take a look at TEVA, MYL, BAX, WPI